Biofarm Bucure (BIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biofarm Bucure (BIO) has a cash flow conversion efficiency ratio of 0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RON28.64 Million ≈ $6.58 Million USD) by net assets (RON534.78 Million ≈ $122.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Biofarm Bucure - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Biofarm Bucure's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Biofarm Bucure Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biofarm Bucure ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MVB Financial Corp
NASDAQ:MVBF
|
-0.070x |
|
Kitex Garments Limited
NSE:KITEX
|
0.174x |
|
Banvit Bandirma Vitaminli Yem Sanayi AS
IS:BANVT
|
-0.067x |
|
White Gold Corp
V:WGO
|
-0.007x |
|
Bredband2 i Skandinavien AB
ST:BRE2
|
0.127x |
|
Modern Avenue Group Co Ltd
SHE:002656
|
-0.380x |
|
Shandong Longquan Pipeline Engineering Co Ltd
SHE:002671
|
0.006x |
|
Sphera Franchise Group SA MiFID Eligible Security
RO:SFG
|
0.689x |
Annual Cash Flow Conversion Efficiency for Biofarm Bucure (2019–2024)
The table below shows the annual cash flow conversion efficiency of Biofarm Bucure from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Biofarm Bucure market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | RON478.26 Million ≈ $109.82 Million |
RON57.59 Million ≈ $13.22 Million |
0.120x | -34.47% |
| 2023-09-30 | RON434.41 Million ≈ $99.75 Million |
RON79.83 Million ≈ $18.33 Million |
0.184x | +140.68% |
| 2022-09-30 | RON380.06 Million ≈ $87.27 Million |
RON29.02 Million ≈ $6.66 Million |
0.076x | -63.27% |
| 2021-09-30 | RON332.79 Million ≈ $76.41 Million |
RON69.18 Million ≈ $15.89 Million |
0.208x | +53.41% |
| 2020-09-30 | RON291.55 Million ≈ $66.94 Million |
RON39.51 Million ≈ $9.07 Million |
0.136x | -52.22% |
| 2019-09-30 | RON257.23 Million ≈ $59.06 Million |
RON72.96 Million ≈ $16.75 Million |
0.284x | -- |
About Biofarm Bucure
Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescr… Read more